Global Biosurgery Market Size to Reach USD 19.79 Billion in 2032 | Emergen Research

Increasing prevalence of chronic disorders is a key factor driving market revenue growth

Vancouver, Aug. 24, 2023 (GLOBE NEWSWIRE) — The global biosurgery market reached a valuation of USD 13.55 Billion in 2022. Current analysis by Emergen Research indicates that the market is poised to sustain a consistent compound annual growth rate (CAGR) of 3.8% throughout the forecast period. This growth is primarily attributed to the escalating patient demand for enhanced blood loss management and the escalating prevalence of chronic ailments.

Bio-surgery involves an innovative approach termed larva or maggot therapy, which serves as a topical treatment option. This method is employed for wound healing in cases where antibiotics prove ineffective and for addressing infections. Notably, this surgical debridement technique exhibits promising outcomes.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1775

Within the context of health concerns, osteoporosis represents a significant challenge. In the United States, the condition impacts an estimated 10 million individuals aged 50 and above. The demographic primarily affected comprises women; however, approximately 2 million men are also influenced. Furthermore, a substantial number of individuals, exceeding 43 million, are characterized by low bone mass, thus elevating their susceptibility to osteoporosis.

The prevalence of osteoporotic fractures further accentuates the gravity of this health issue. Statistics indicate that at least one in every three women and one in every five men will encounter an osteoporosis-related fracture over the course of their lifetime.

Nevertheless, a significant hurdle in the biosurgery market pertains to the substantial costs associated with biosurgery products. This factor stands as a potential constraint on the overall revenue of the market. Particularly in developing nations, the patient demographic targeted by these products tends to favor conventional alternatives during surgical procedures due to the elevated expenses associated with biosurgery solutions. This inclination is further influenced by the prevailing hospital reimbursement landscape.

The cost-effectiveness consideration is underscored by the inherent expensiveness of bio-surgeries, which encompasses both pre-operative and post-operative expenses. This financial aspect can pose challenges to the broader adoption of biosurgery interventions.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1775

Scope of Research

Major Companies and Competitive Landscape

The global biosurgery market is fragmented, with many medium and large-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing advanced new surgical tools. Some major players included in the global biosurgery market report are:

• Baxter International Inc.
• Becton, Dickinson and Company
• Johnson & Johnson Services, Inc.
• Medtronic Plc
• B. Braun SE
• Integra Lifesciences Holdings Corporation
• CryoLife, Inc.
• Hemostasis, LLC
• Betatech Medical
• Kuros Biosciences A.G.

Strategic Development

• On July 2021, Becton, Dickinson and Company (BD), a leading provider of medical technology, acquired Tepha, Inc., a pioneer in development and production of unique resorbable polymer technology. Tepha’s patented resorbable polymer (Poly 4-hydroxybutyric acid, P4HB) technology platform increases innovation potential of BD’s surgical mesh portfolio and pushes the business into completely new fields of soft tissue regeneration, repair, and repair.
• On February 2021, EndoClot Plus, Inc. (EPI) declared that EndoClot Polysaccharide Hemostatic System (EndoClot PHS), a cutting-edge medication that helps gastroenterologists reliably and quickly control bleeding, received Food and Drug Administration (FDA) approval. Using the use of a flexible endoscope, a starch-based powder hemostat called EndoClot PHS is applied directly to the bleeding location. Blood can be swiftly concentrated using proprietary Absorbable Modified Polymer (AMP) powder to hasten the body’s natural clotting process.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/1775

Some Key Highlights From the Report

• The bone graft substitutes segment accounted for significantly large revenue share in the global biosurgery market in 2022. This is due increasing number of orthopedic procedures as well as rising frequency of bone illnesses including tumors and infections. In addition, market revenue growth is also driven by rising demand for synthetic replacements and number of product approvals by different agencies.
• The orthopedic surgery segment revenue is expected to account for largest revenue share in the global biosurgery market in 2022. This is owing to increasing number of joint reconstruction surgeries, burden of orthopedic disorders, trauma, and accident cases. These joint procedures are found to occur often among elderly people, as these people have weaker bones and are therefore more susceptible to accidents and other bone abnormalities.
• The North America is expected to account for largest revenue share in the global biosurgery market over the forecast period. This is due increasing prevalence of chronic disorders, such as cardiovascular and orthopedic in this region, and presence of better healthcare infrastructure.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/biosurgery-market

Emergen Research has segmented the global biosurgery market on the basis of product, application, end-use, and region:

• Product Outlook (Revenue, USD Billion; 2019-2032)

• • Bone-Graft Substitutes
  • Soft-Tissue Attachments
  • Surgical Sealants
  • Hemostatic Agents
  • Adhesion Barriers
  • Staple Line Reinforcement Agents
  • Others

• Application Outlook (Revenue, USD Billion; 2019-2032)

• • General Surgery
  • Orthopedic Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Others

• End-Use Outlook (Revenue, USD Billion; 2019-2032)

• • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others
• Regional Outlook (Revenue, USD Billion; 2019–2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. France
    3. UK
    4. Italy
    5. Spain
    6. Benelux
    7. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Turkey
    5. Rest of Middle East & Africa

Curated Reports You Shouldn’t Miss: Dive In Now!

Medical Waste Management Market, By Type of Waste (Hazardous Waste and Non-Hazardous Waste), By Treatment (Incineration, Autoclaving, Chemical Treatment, and Others), By Treatment Site, By Service, and By Region Forecast to 2030

Vulvovaginal Candidiasis Market, By Drug Type (Clotrimazole, Fluconazole, Ketoconazole, and Others), By Route of Administration (Oral, Topical, and Others), By Distribution Channel, and By Region Forecast to 2030

Insulin Delivery Market By Diabetes Type (Type 1 Diabetes, Type 2 Diabetes), By Device Type (Syringes, Pens, Pumps, Others), By Route of Administration (Oral, Subcutaneous Route, Others), By End-use, By Sales Channel, By Region Forecast to 2030

Therapeutic Ultrasound Market By Technology (High Intensity Focused Ultrasound and Extracorporeal Shockwave Lithotripsy), By End-Use (Hospitals, Clinics and Diagnostic Centers), By Application, and By Region Forecast to 2030

Pain Relief Market, By Treatment Type (Drugs and Topical Pain Relief), By Application (Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, and Others), and By Region Forecast to 2030

Precision Surgery Device Market, By Type (Handheld Surgical Devices, Surgical Sutures and Staplers, Electrosurgical Devices), By Application, and By Region Forecast to 2030

Acne Treatment Market Size, Share, Trends, By Product (Retinoids, Antibiotics, Isotretinoin, Others), By Administration (Oral, Topical, Injectable), By End User (Hospitals, Skincare clinics), and By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Biosurgery Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-biosurgery-market